These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

712 related items for PubMed ID: 23134984

  • 1. The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream.
    Kircik LH, Del Rosso JQ.
    J Drugs Dermatol; 2012 Oct; 11(10):1194-8. PubMed ID: 23134984
    [Abstract] [Full Text] [Related]

  • 2. The role of a midpotency topical corticosteroid and the clinical relevance of formulation characteristics in the management of commonly encountered eczematous and inflammatory dermatoses in adults and children: focus on the pharmacologic properties of clocortolone pivalate 0.1% cream.
    Del Rosso JQ, Kircik LH.
    J Drugs Dermatol; 2013 Feb; 12(2):s5-s10. PubMed ID: 23377405
    [Abstract] [Full Text] [Related]

  • 3. A Comprehensive Review of Clocortolone Pivalate 0.1% Cream: Structural Development, Formulation Characteristics, and Studies Supporting Treatment of Corticosteroid-responsive Dermatoses.
    Del Rosso JQ, Kircik L.
    J Clin Aesthet Dermatol; 2012 Jul; 5(7):20-4. PubMed ID: 22798972
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of clocortolone pivalate 0.1 percent cream in the treatment of atopic dermatitis, contact dermatitis, and seborrheic dermatitis.
    Nierman MM.
    Cutis; 1981 Jun; 27(6):670-1. PubMed ID: 6453703
    [No Abstract] [Full Text] [Related]

  • 5. Clocortolone pivalate cream 0.1% used concomitantly with tacrolimus ointment 0.1% in atopic dermatitis.
    Torok HM, Maas-Irslinger R, Slayton RM.
    Cutis; 2003 Aug; 72(2):161-6. PubMed ID: 12953943
    [Abstract] [Full Text] [Related]

  • 6. Clocortolone pivalate: a topical corticosteroid with a unique structure.
    Kircik LH.
    J Drugs Dermatol; 2013 Feb; 12(2):s3-4. PubMed ID: 23377404
    [Abstract] [Full Text] [Related]

  • 7. Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolone pivalate 0.1% cream.
    Del Rosso JQ, Kircik LH.
    J Drugs Dermatol; 2014 Jul; 13(7):s77-83. PubMed ID: 25007376
    [Abstract] [Full Text] [Related]

  • 8. A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay.
    Kircik LH.
    J Drugs Dermatol; 2014 May; 13(5):582-5. PubMed ID: 24809882
    [Abstract] [Full Text] [Related]

  • 9. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
    Warshaw EM, Wohlhuter RJ, Liu A, Zeller SA, Wenner RA, Bowers S, Schultz JC, Katz HI, McCormick CL, Parneix-Spake A.
    J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
    [Abstract] [Full Text] [Related]

  • 10. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
    Elewski B.
    Clin Dermatol; 2009 Aug; 27(6 Suppl):S48-53. PubMed ID: 19878781
    [Abstract] [Full Text] [Related]

  • 11. Adherence to clocortolone pivalate cream 0.1% in a pediatric population with atopic dermatitis.
    Conde JF, Kaur M, Fleischer AB, Tusa MG, Camacho F, Feldman SR.
    Cutis; 2008 May; 81(5):435-41. PubMed ID: 18543596
    [Abstract] [Full Text] [Related]

  • 12. Clocortolone pivalate: a paired comparison clinical trial of a new topical steroid in eczema/atopic dermatitis.
    Rosenthal AL.
    Cutis; 1980 Jan; 25(1):96-8. PubMed ID: 6986236
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic efficacy and safety of loratadine syrup in childhood atopic dermatitis treated with mometasone furoate 0.1 per cent cream.
    Chunharas A, Wisuthsarewong W, Wananukul S, Viravan S.
    J Med Assoc Thai; 2002 Apr; 85(4):482-7. PubMed ID: 12118496
    [Abstract] [Full Text] [Related]

  • 14. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
    Rigopoulos D, Ioannides D, Kalogeromitros D, Gregoriou S, Katsambas A.
    Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
    [Abstract] [Full Text] [Related]

  • 15. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Scott G, Abrams K.
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [Abstract] [Full Text] [Related]

  • 16. Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults.
    Papp KA, Papp A, Dahmer B, Clark CS.
    J Am Acad Dermatol; 2012 Jul; 67(1):e11-5. PubMed ID: 22101215
    [Abstract] [Full Text] [Related]

  • 17. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
    Seckin D, Gurbuz O, Akin O.
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
    [Abstract] [Full Text] [Related]

  • 18. Four cases of sebopsoriasis or seborrheic dermatitis of the face and scalp successfully treated with 1a-24 (R)-dihydroxycholecalciferol (tacalcitol) cream.
    Nakayama J.
    Eur J Dermatol; 2000 Mar; 10(7):528-32. PubMed ID: 11056423
    [Abstract] [Full Text] [Related]

  • 19. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH, Lee KH, Jautova J, Wohlrab J, Guettner A, Mizutani G, Hultsch T.
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [Abstract] [Full Text] [Related]

  • 20. An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV.
    de Moraes AP, de Arruda EA, Vitoriano MA, de Moraes Filho MO, Bezerra FA, de Magalhães Holanda E, de Moraes ME.
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):596-601. PubMed ID: 17447972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.